Bernhard Liegl | VP Global Clinical Development

Bernhard Liegl, VP Global Clinical Development, Celerion

As Vice President Global Clinical Development Europe, Bernhard Liegl, based in Vienna, is responsible for driving clinical development strategies and providing oversight for studies in specialized patient populations throughout the world. Mr. Liegl brings 15 years of clinical research experience to this role, spanning a wide range of therapeutic areas, with a particular focus in oncology, vaccines, cancer immunotherapy, personalized medicine and autoimmune disorders.  He has extensive experience in building and managing global teams, leading the development of drugs and biologics. Prior to joining Celerion, Mr. Liegl served as Chief Financial Officer, Chief Operations Officer and Executive Director Clinical Operations for Assign Clinical Research, playing a pivotal role in the growth and expansion of this business.

back to speakers